What is the current price and volume for FH.NE stock?

FH.NE stock is trading at **C$0.01** with intraday volume of **929,483** shares. The stock’s average volume is **4,885,995**, so today’s trade shows heightened interest but still limited liquidity for a microcap.

What are sensible trade targets for an oversold bounce in FH.NE stock?

For an oversold-bounce strategy use entries between **C$0.005** and **C$0.01**, a stop below **C$0.005**, initial take-profit at **C$0.02** and a secondary target near **C$0.05**. These targets balance intraday range and volatility.

How does Meyka AI rate FH.NE stock and what does the forecast say?

Meyka AI rates FH.NE **61.89/100 (Grade B, HOLD)**. Meyka AI's forecast model projects a **C$0.02** 12-month median target from the current **C$0.01**, noting that forecasts are model-based and not guarantees.

What are the main risks when trading FH.NE stock?

Main risks include low liquidity, microcap volatility, negative EPS (**-0.02**), weak current ratio (**0.44**), and dependence on event-driven catalysts such as trial outcomes or IP deals. Position sizing and strict stops are essential.

CA Stocks

FH.NE Filament Health (NEO) at C$0.01 on 11 Feb 2026: Oversold bounce setup

ByHuzaifa Zahoor February 11, 2026February 11, 2026

FH.NE stock trades at C$0.01 on 11 Feb 2026 after a sharp intraday slip, marking a -33.33% move and heavy intraday interest of 929,483 shares. Filament Health Corp. (FH.NE) on the NEO exchange operates in Canadian healthcare research and extraction of natural psychedelics. The price sits well below the 50-day and 200-day averages, creating a classic oversold bounce candidate for short-term traders looking for a defined risk entry. Meyka AI’s real-time signals identify the setup, but liquidity, negative earnings and small market cap demand strict risk control.